It is a contract research service where a specialized lab uses Systematic Evolution of Ligands by EXponential Enrichment (SELEX) to discover and develop DNA or RNA aptamers that bind with high affinity and specificity to a target of your choice related to stem cells.
Aptamers are often called “chemical antibodies.” They are short, single-stranded oligonucleotides that fold into unique 3D shapes, allowing them to bind to targets like proteins, small molecules, or even whole cells.
The service can be tailored to screen for aptamers against:
Specific Cell Surface Markers: (e.g., CD34, CD133, SSEA-4, TRA-1-60) for identification and isolation.
Whole Live Stem Cells: To get aptamers that recognize the unique molecular signature of a specific stem cell type (e.g., mesenchymal stem cells, cancer stem cells, pluripotent stem cells).
Differentiation State-Specific Targets: To distinguish between pluripotent, progenitor, and fully differentiated cells.
Specific Stem Cell-Derived Products: (e.g., exosomes, vesicles).
A professional service provider will guide you through these stages:
| Phase | Description | Your Input |
|---|---|---|
| 1. Project Design | Defining the target (specific protein, cell line, primary cells), counter-selection cells (to ensure specificity), and desired aptamer properties (e.g., Kd, nuclease resistance). | Provide target cells, control cells, and scientific goals. |
| 2. Library & Selection | Performing iterative SELEX rounds. A vast random oligonucleotide library (10^14-10^15 sequences) is incubated with the target. Bound sequences are recovered, amplified by PCR/RT-PCR, and used for the next round. Stringency increases over time. | Often minimal; the provider handles the complex biochemistry. |
| 3. Counter-Selection | To eliminate non-specific binders, the pool is incubated with non-target cells (e.g., differentiated cells, other cell types). Unbound sequences are then used for positive selection. This is crucial for specificity. | Provide well-characterized control cell lines. |
| 4. Sequencing & Cloning | The final enriched pool is deep-sequenced (NGS). Bioinformatic analysis identifies candidate families based on sequence homology and predicted structure. | Review data analysis reports. |
| 5. Synthesis & Validation | Top candidate aptamers are chemically synthesized, often with modifications (e.g., F, biotin, fluorescent tags). Provider validates binding (Flow Cytometry, Confocal Microscopy), affinity (SPR, BLI), and specificity. | Receive final aptamer sequences and validation data. |
| 6. Functional Assay (Optional) | Testing aptamer functionality in the intended application (e.g., cell sorting, inhibition of a signaling pathway). | Collaborate on assay design. |
Identification & Isolation: Fluorescently tagged aptamers can be used like antibodies in FACS or on magnetic beads for label-free or gentle cell sorting.
In Vivo Imaging: Aptamers can be conjugated to imaging agents to track stem cells after transplantation.
Targeted Delivery: Aptamers can deliver drugs, toxins, or nanoparticles specifically to stem cells or cancer stem cells.
Cell Function Regulation: Some aptamers may act as agonists or antagonists to cell surface receptors, influencing differentiation or proliferation.
Quality Control: Aptamer panels can serve as reproducible, synthetic reagents to characterize stem cell batches.
Synthetic: Produced chemically with no batch-to-batch variation.
Small Size: Better tissue penetration.
Modifiable: Easy to label with dyes, quenchers, or functional groups without affecting binding.
Reversible Denaturation: Can be renatured repeatedly.
Non-Immunogenic: Typically, no immune response.
Expertise in Cell-SELEX: Experience with live, fragile stem cells is critical.
Proven Track Record: Publications or case studies in stem cell biology.
Comprehensive Validation Package: Don’t just accept sequences. Insist on Kd measurements, specificity profiles (vs. relevant cell types), and clear binding images.
Customization: Ability to tailor the process to your specific cell type and goals.
Technical Specifications: Types of SELEX offered (e.g., Capillary Electrophoresis-SELEX, Cell-SELEX, Toggle-SELEX), NGS depth, and modification options.
Intellectual Property (IP) Clarity: Clear agreement on ownership of the discovered aptamer sequences.
Aptamer Group: Well-known for their Optimer technology and extensive experience in cell-SELEX.
Base Pair Biotechnologies: Offers custom aptamer development with a strong focus on cell targets.
AptaDiscovery: Specializes in cell-SELEX and complex target SELEX.
AM Biotech: Has a proprietary screening platform.
Academic Core Facilities: Some major universities have aptamer screening cores (e.g., University of Florida, NIH-funded centers).
Aptamer Affinity Optimization
Aptamer Library Construction
Customized Aptamer Selection
High-throughput Aptamer Screening
High-Throughput Sequencing SELEX Aptamer Screening Service
Conventional SELEX Aptamer Screening Service
Negative SELEX Aptamer Screening Service
Toggle-SELEX Aptamer Screening Service
Capture-SELEX Aptamer Screening Service
Surface Plasmon Resonance SELEX Aptamer Screening Service
Capillary Electrophoresis SELEX Aptamer Screening Service
Magnetic Bead-based SELEX Aptamer Screening Service
Toggle-SELEX Aptamer Screening Service
Negative Aptamer Selection- A Practical Guide to Improving Aptamer Specificity in SELEX
selexkmdbio-Cell Nucleic Acid Aptamer Screening Service
Aptamer Screening- Current Methods and Future Trend towards Non-SELEX Approach
Aptamer Screening Service-Subtractive SELEX
Aptamer Screening Service-Counter SELEX
Aptamer Screening Service-HT-SELEX
Aptamer Screening Service-NGS-SELEX
Aptamer Screening Service-Multi-Round SELEX Screening
Whole Cell-SELEX Aptamer Screening Service
Membrane Protein Aptamer Screening Service
Aptamer Screening Service for Drug Discovery
Aptamer Live Cell SELEX Service
Classical SELEX Service for Aptamer
Aptamer Selection and Identification
Aptamer Screening Process and Applications Overview